Showing results (1-10 of 536) with videos related to

Sort By:
Pageof 54
Journal of Renal Care|July 1, 2010
Lipids in chronic kidney diseaseDavid Lewis, Richard Haynes, Martin J Landray
Nature Clinical Practice. Nephrology|January 21, 2009
Reassuring results with regard to the effect of donor nephrectomy on cardiovascular outcomesRichard Haynes, Martin J Landray, Christopher G Winearls
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 21, 2014
Neprilysin inhibition in chronic kidney diseaseParminder Judge, Richard Haynes, Martin J Landray, et al.
Clinical Medicine (London, England)|September 29, 2023
Delivering trials in the NHS: more than worth itRichard Haynes, Marion Mafham, Cheng Hock Toh, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 12, 2014
Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP)Richard Haynes, Natalie Staplin, Jonathan Emberson, et al.
Lancet (London, England)|August 1, 2014
Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial, Richard Haynes, Paul Harden, et al.
Clinical Therapeutics|August 27, 2019
Serious Adverse Effects of Extended-release Niacin/Laropiprant: Results From the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) TrialRichard Haynes, Elsa Valdes-Marquez, Jemma C Hopewell, et al.
Circulation. Cardiovascular Quality and Outcomes|July 14, 2016
Effects of Vascular and Nonvascular Adverse Events and of Extended-Release Niacin With Laropiprant on Health and Healthcare CostsSeamus Kent, Richard Haynes, Jemma C Hopewell, et al.
Trials|December 7, 2019
Investigating modifications to participant information materials to improve recruitment into a large randomized trial, Richard Haynes, Fang Chen, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 25, 2016
Use of Causal Diagrams to Inform the Design and Interpretation of Observational Studies: An Example from the Study of Heart and Renal Protection (SHARP)Natalie Staplin, William G Herrington, Parminder K Judge, et al.
Pageof 54